Skip to main content
Thailand plant
ACG

PESTLE Analysis

External Pressures Creating Opportunity for ACG

Post-Consumer Recycled (PCR) Opportunity in Pharma Blister Packaging - India

PESTLE Analysis

PCR
Opportunity
🏛️

Political

India's Plastic Waste Rules & EPR Guidelines

Impact: Launch compliance-ready PCR blisters

💰

Economic

30B pharma market by 2030

Impact: Capture 10% CAGR demand with cost management

👥

Social

83% prefer eco-friendly packaging

Impact: First-mover advantage as sustainable supplier

⚙️

Technological

PVC-free solutions by global competitors

Impact: Leverage in-house engineering for recyclable blisters

📜

Legal

DCGI/FDA extractables & leachables requirements

Impact: Early validation = "ready-to-approve" supplier

🌿

Environmental

3.5M tonnes plastic waste annually

Impact: Brand as "world's cleanest blister provider"

Timeline

2016

Plastic Waste Management Rules introduced

PWM establishes recycling obligations

2022

EPR Guidelines implemented

Extended Producer Responsibility targets set

2025

Recycled PET in food packaging

Regulatory approval for food-grade rPET

2030

30B Indian pharma market

Plastic neutrality achieved

Capsules Desktop Banner Everything tablets

Opportunity

PCR Blister Packaging Opportunity

ACG stands at the intersection of regulatory compliance and market demand

1

Market Leadership

First-mover advantage in India's sustainable packaging

2

Regulatory Compliance

EPR-ready solutions for pharma clients

3

30B Market

10% CAGR growth in blister packaging demand

Packaging materials Pharma icon Nutra icon